相关实验视频

Updated: Jul 11, 2025

Palatable Western-style Cafeteria Diet as a Reliable Method for Modeling Diet-induced Obesity in Rodents
09:10

Palatable Western-style Cafeteria Diet as a Reliable Method for Modeling Diet-induced Obesity in Rodents

Published on: November 1, 2019

10.8K

昆 (Chenopodium quinoa) 是一种含有的植物. 补充的餐厅饮食改善了老鼠的葡萄糖不耐受

Hatice Ozcaliskan Ilkay1,2, Derya Karabulut3, Gonca Kamaci Ozocak4

  • 1Faculty of Health Sciences, Department of Nutrition and Dietetics Hacettepe University Ankara Turkey.

Food science & nutrition
|November 16, 2023
PubMed
概括

昆的消费可能有助于预防肥胖和相关的代谢问题,如葡萄糖不耐受和肝脏脂肪积累. 这项研究表明,在食高脂肪饮食的老鼠中,可改善葡萄糖平衡和胰腺β细胞功能.

关键词:
咖啡馆饮食的饮食葡萄糖耐受性是一种耐受性.肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖奎诺亚 (quinoa) 是一种菜.鼠类 鼠类 鼠类 鼠类 鼠类

更多相关视频

A Model of Chronic Nutrient Infusion in the Rat08:18

A Model of Chronic Nutrient Infusion in the Rat

Published on: August 14, 2013

12.8K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

68.5K

相关概念视频

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
210
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
331